🔎 Trials Near Me

Home › Multiple System Atrophy › Tennessee

Multiple System Atrophy clinical trials in Tennessee

8 studies for Multiple System Atrophy are looking for participants at sites in Tennessee.

Cities in Tennessee

A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy

  • Teva Investigational Site 15874, Nashville
RecruitingPhase 2
Ages 30 to 75 · All sexes · Updated Jul 20, 2026 · NCT06568237

Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms

  • Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville
Recruiting
Ages 40 to 80 · All sexes · Updated Jul 2, 2026 · NCT04782830

Natural History Study of Synucleinopathies

  • Vanderbilt Univeristy, Nashville
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT01799915

CPAP for the Treatment of Supine Hypertension

  • Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville
Recruiting
Ages 40 to 80 · All sexes · Updated Apr 7, 2026 · NCT05489575

[18F]F-DOPA Imaging in Patients With Autonomic Failure

  • Vanderbilt University Medical Center, Nashville
RecruitingPhase 1Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Mar 16, 2026 · NCT04246437

Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine Hypertension

  • Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville
Recruiting
Ages 18 to 80 · All sexes · Updated Jan 16, 2026 · NCT03042988

Treatment of Supine Hypertension in Autonomic Failure (CPAP)

  • Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville
Recruiting
Ages 18 to 85 · All sexes · Updated Nov 6, 2025 · NCT03312556

Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

  • Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville
RecruitingPhase 1
Ages 40 to 80 · All sexes · Updated Oct 14, 2025 · NCT02897063

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.